Biochemical Engineering
Rentschler Biopharma to Begin Construction of New Manufacturing Facility
13th August 2021
Rentschler Biopharma has announced that it has broken ground at its new production site, adjacent to its existing Milford, Mass., site where it will build the Rentschler Biopharma Manufacturing Center US, a new facility that will add 22,000 ft2 of manufacturing cleanroom space and house four new 2000-L single-use bioreactors. The company expects the RBMC US to be operational in late 2023. Source: Biopharm International 13/8/2021
Back to group news